SDE-100 a stochastic cysteine linked Vedotin ADC: Assessing comparability of extent and site of conjugation using multiple orthogonal analytical approaches

Poster Presentation1 min read 28th Apr 2023

Share via email Share via LinkedIn

Download resource

Share via email Share via LinkedIn

Popular articles

ADCs at Sterling

News2 min read

GlycoNex Announces Manufacturing Agreement with Sterling for GNX102-ADC Clinical Trial Production Read more

News2 min read

Sterling Expands GMP ADC Manufacturing Capacity at Deeside, UK Read more

Mass spectrometry

Infographic1 min read

Measurement of ADC stability in plasma and serum via mass spectrometry analysis Read more

ADCs

One pager2 min read

Antibody drug conjugation (ADC) overview Read more

Preview of the applying analytical method validation to cell-based potency assays whitepaper

Whitepaper12 min read

Applying analytical method validation to cell-based potency assays Read more

Sterling's Deeside, UK facility

News2 min read

Sterling Expands Bioanalytical Capabilities at Deeside, UK Site Read more

Sign up for updates

Be the first to see the latest articles and updates from industry leaders, delivered straight to your inbox

Name(Required)

Email(Required)

Company Name(Required)

This field is hidden when viewing the form

Prospect Source

Please click here for our privacy policy

This field is for validation purposes and should be left unchanged.

Service. Passion. Science.

PDMO^® is registered in the U.S. Patent and Trademark Office.

PDMO^® is a registered trademark of Sterling Pharma Solutions Limited (EUIPO and UKIPO). All rights reserved.

Sterling Pharma Solutions Limited. Registration number: 05712796. Registered office address: Sterling Place, Dudley, Cramlington, Northumberland NE23 7QG. Registered in England.